use of mehamudgara rasa in diabetic neuropathy
Phase 2
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2019/07/020275
- Lead Sponsor
- DR ASHISH MHATRE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients with clinical positive history of type 2 diabetes mellitus having the symptoms of diabetic neuropathy (peripheral) are selected for the present study
2) NDS score between 3 to 8 will be included
3)abnormal vibration perception study will be included
Exclusion Criteria
ï?§The cases with complications like diabetic gangrene, carbuncles, diabetic coma, retinopathy, IDDM will be excluded from present clinical trials.
ï?§Any major diseases like Kochâ??s, IHD, AIDS etc associated with diabetes mellitus.
ï?§Thyroid dysfunction, Patients on Corticosteroid Therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate clinical Efficacy of Meha-Mudgara Rasa in the management of Madhumehajanya Nadipratan Shotha w.r.t Diabetes NeuropathyTimepoint: Initial Day 1st day, 10th day, 20th day ,30th day
- Secondary Outcome Measures
Name Time Method to compare the clinical outcomes of both the group viz .mehamudgara rasa & pregabalinTimepoint: 1yr